{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:57:11Z","timestamp":1773842231132,"version":"3.50.1"},"reference-count":32,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Translocation of chromosomes 11 and 14 [t(11;14)(q13;32)] is the most common primary translocation in multiple myeloma (MM). Patients harboring t(11;14) exhibit high response rates to BCL-2 inhibitors, underscoring the importance of rapid detection to guide treatment decisions. While fluorescence in situ hybridization (FISH) remains the gold standard for detecting this abnormality, its application is limited by challenges related to speed, accessibility, and cost. Objectives and Methods: This study evaluated a deep-learning-based method for detecting t(11;14) using scans of H&amp;E-stained bone marrow biopsies from 268 untreated MM patients (147 males and 121 females). Results: Among these patients, 47 (17.5%) were diagnosed with smoldering MM, while 218 (81.4%) had active MM, including 22 (8.2%) that presented with concomitant amyloidosis. FISH analysis detected cytogenetic abnormalities in 191 cases (71%), with t(11;14) identified in 73 cases (27%) and a median of 26% positive cells in t(11;14)-positive cases. The AI algorithm achieved 88% sensitivity, 83.1% specificity, 84.3% accuracy, and an area under the receiver operating characteristic curve (AUROC) of 0.85 in conclusive results. The algorithm\u2019s performance was positively influenced by a higher percentage of plasma cells in the bone marrow (p &lt; 0.001), active versus smoldering MM (p = 0.009), the presence of lytic lesions (p = 0.023), and lower hemoglobin levels (p = 0.025). Conclusions: These findings suggest that this AI approach could facilitate rapid screening for FISH analysis, although further enhancements are necessary for its clinical application in MM management.<\/jats:p>","DOI":"10.3390\/cancers17111733","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T07:04:28Z","timestamp":1747897468000},"page":"1733","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Deep-Learning-Based Prediction of t(11;14) in Multiple Myeloma H&amp;E-Stained Samples"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6288-3059","authenticated-orcid":false,"given":"Nadav","family":"Kerner","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7954-4486","authenticated-orcid":false,"given":"Dov","family":"Hershkovitz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"},{"name":"Pathology Department, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Trestman","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"},{"name":"Hematology Division, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamir","family":"Shragai","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"},{"name":"Hematology Division, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hila Lederman","family":"Nachmias","sequence":"additional","affiliation":[{"name":"Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael C.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"},{"name":"Hematology Division, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2589-8473","authenticated-orcid":false,"given":"Tomer","family":"Ziv-Baran","sequence":"additional","affiliation":[{"name":"School of Public Health, Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irit","family":"Avivi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"},{"name":"Hematology Division, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"ref_1","first-page":"2950","article-title":"Multiple Myeloma with t(11;14): Unique Biology and Evolving Landscape","volume":"12","author":"Bal","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood.V99.10.3735","article-title":"Myeloma and the t(11;14)(Q13;Q32); Evidence for a Biologically Defined Unique Subset of Patients","volume":"99","author":"Fonseca","year":"2002","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1182\/blood-2007-02-069625","article-title":"Immunoglobulin Gene Rearrangements and the Pathogenesis of Multiple Myeloma","volume":"110","author":"Fenton","year":"2007","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/sj.leu.2403091","article-title":"T(11;14) and t(4;14) Translocations Correlated with Mature Lymphoplasmacytoid and Immature Morphology, Respectively, in Multiple Myeloma","volume":"17","author":"Garand","year":"2003","journal-title":"Leukemia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1309\/4W8E-8F4K-BHUP-UBE7","article-title":"The (11;14)(Q13;Q32) Translocation in Multiple Myeloma: A Morphologic and Immunohistochemical Study","volume":"113","author":"Hoyer","year":"2000","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S1470-2045(20)30525-8","article-title":"Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma (BELLINI): A Randomised, Double-Blind, Multicentre, Phase 3 Trial","volume":"21","author":"Kumar","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.1200\/JCO.2024.42.16_suppl.7510","article-title":"Efficacy of Venetoclax-Dexamethasone (VenDex) v Pomalidomide-Dexamethasone (PomDex) in Patients (Pts) with t(11;14)-Positive Relapsed\/Refractory Multiple Myeloma [t(11;14)+ RRMM]: Phase 3 CANOVA Study Biomarker Subgroup Analysis","volume":"42","author":"Bahlis","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1182\/blood-2020-142054","article-title":"Efficacy of Venetoclax Based Regimens in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis","volume":"136","author":"Hashim","year":"2020","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/10428194.2019.1709835","article-title":"A Single-Center Retrospective Cohort Analysis of Venetoclax in Relapsed\/Refractory Multiple Myeloma","volume":"61","author":"Kambhampati","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10637-024-01471-x","article-title":"Exposure-Response Relationships of Venetoclax in Combination with Carfilzomib and Dexamethasone in Relapsed\/Refractory t(11;14) Multiple Myeloma Patients","volume":"42","author":"Badawi","year":"2024","journal-title":"Investig. New Drugs"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/leu.2009.174","article-title":"International Myeloma Working Group Molecular Classification of Multiple Myeloma: Spotlight Review","volume":"23","author":"Fonseca","year":"2009","journal-title":"Leukemia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10114","DOI":"10.1182\/blood-2022-158076","article-title":"Current Testing Practices for t(11;14) Rearrangements in Patients with Newly Diagnosed Multiple Myeloma in the United States","volume":"140","author":"Baughn","year":"2022","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mne.2018.10.006","article-title":"Fluorescence in Situ Hybridization (FISH): History, Limitations and What to Expect from Micro-Scale FISH?","volume":"1","author":"Huber","year":"2018","journal-title":"Micro Nano Eng."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/GIM.0b013e3182227295","article-title":"Section E9 of the American College of Medical Genetics Technical Standards and Guidelines: Fluorescence in Situ Hybridization","volume":"13","author":"Mascarello","year":"2011","journal-title":"Genet. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ha, J., Cho, H., Lee, T.G., Shin, S., Chung, H., Jang, J.E., Kim, S.J., Cheong, J.W., Lee, S.T., and Kim, J.S. (2022). Cytogenetic Testing by Fluorescence in Situ Hybridization Is Improved by Plasma Cell Sorting in Multiple Myeloma. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-11676-w"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/S1470-2045(19)30154-8","article-title":"Digital Pathology and Artificial Intelligence","volume":"20","author":"Niazi","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/ijlh.14110","article-title":"Applied Machine Learning in Hematopathology","volume":"45","author":"Dehkharghanian","year":"2023","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s43018-022-00436-4","article-title":"Artificial Intelligence in Histopathology: Enhancing Cancer Research and Clinical Oncology","volume":"3","author":"Shmatko","year":"2022","journal-title":"Nat. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"051802","DOI":"10.1117\/1.JMI.10.5.051802","article-title":"Artificial Intelligence and Digital Pathology: Clinical Promise and Deployment Considerations","volume":"10","author":"Zarella","year":"2023","journal-title":"J. Med. Imaging"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Andrade, C.L.B., Ferreira, M.V., Alencar, B.M., Junior, A.M.A., Lopes, T.J.S., dos Santos, A.S., dos Santos, M.M., Silva, M.I.C.S., Rosa, I.M.D.R.P., and Filho, J.L.S.B. (2024). Enhancing Diagnostic Accuracy of Multiple Myeloma through ML-Driven Analysis of Hematological Slides: New Dataset and Identification Model to Support Hematologists. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-61420-9"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1158\/0008-5472.CAN-22-2654","article-title":"Deep Learning Enables Spatial Mapping of the Mosaic Microenvironment of Myeloma Bone Marrow Trephine Biopsies","volume":"84","author":"Hagos","year":"2024","journal-title":"Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Allegra, A., Tonacci, A., Sciaccotta, R., Genovese, S., Musolino, C., Pioggia, G., and Gangemi, S. (2022). Machine Learning and Deep Learning Applications in Multiple Myeloma Diagnosis, Prognosis, and Treatment Selection. Cancers, 14.","DOI":"10.3390\/cancers14030606"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Perry, C., Greenberg, O., Haberman, S., Herskovitz, N., Gazy, I., Avinoam, A., Paz-Yaacov, N., Hershkovitz, D., and Avivi, I. (2023). Image-Based Deep Learning Detection of High-Grade B-Cell Lymphomas Directly from Hematoxylin and Eosin Images. Cancers, 15.","DOI":"10.3390\/cancers15215205"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7846","DOI":"10.1182\/blood-2022-159522","article-title":"A Sensitive Machine Learning-Based Approach to Assess Multiple Myeloma t(11;14) Genetic Subtype from Histopathology Images","volume":"140","author":"Liu","year":"2022","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7158","DOI":"10.1182\/blood-2023-190686","article-title":"Machine Learning Models Predict Molecular Genetic Subtypes of Multiple Myeloma from Whole-Slide Bone Marrow Aspirate Smears","volume":"142","author":"Lewis","year":"2023","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/ajcp\/aqae129.343","article-title":"Deep Learning-Based Integration of Morphology and Immunophenotype Predicts Molecular Genetic Subtypes of Multiple Myeloma","volume":"162","author":"Lewis","year":"2024","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International Staging System for Multiple Myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/ajh.27422","article-title":"Multiple Myeloma: 2024 Update on Diagnosis, Risk-Stratification, and Management","volume":"99","author":"Rajkumar","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e36660","DOI":"10.1097\/MD.0000000000036660","article-title":"New Diagnostic Strategy for Multiple Myeloma: A Review","volume":"102","author":"Xu","year":"2023","journal-title":"Medicine"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zhu, R., He, H., Chen, Y., Yi, M., Ran, S., Wang, C., and Wang, Y. (2024). Deep Learning for Rapid Virtual H&E Staining of Label-Free Glioma Tissue from Hyperspectral Images. Comput. Biol. Med., 180.","DOI":"10.1016\/j.compbiomed.2024.108958"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Banna, G.L., Olivier, T., Rundo, F., Malapelle, U., Fraggetta, F., Libra, M., and Addeo, A. (2019). The Promise of Digital Biopsy for the Prediction of Tumor Molecular Features and Clinical Outcomes Associated With Immunotherapy. Front. Med., 6.","DOI":"10.3389\/fmed.2019.00172"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/11\/1733\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:38:17Z","timestamp":1760031497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/11\/1733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["cancers17111733"],"URL":"https:\/\/doi.org\/10.3390\/cancers17111733","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]}}}